Rucha Patil: Privilege to Speak at the West Bengal Hemophilia Conclave 2026 on HTA in Hemophilia Therapies
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”It was a privilege to speak at the West Bengal Hemophilia Conclave 2026, held on 4 July 2026 at Taj Taal Kutir, Kolkata.
I had the opportunity to deliver a lecture on ‘Cost-effectiveness and Health Technology Assessment (HTA) in Hemophilia Therapies: The ICMR Perspective,’ highlighting the role of evidence-based evaluation in improving access to sustainable hemophilia care in India.
My sincere thanks to the Program Director, Prof. (Dr.) Maitreyee Bhattacharyya, for the kind invitation. It was an honour to have the session chaired by the eminent Dr. Prakas Kumar Mandal and Dr. Madhumita Nandi.”
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia